Diabetes fuels periodontal lesions via GLUT1-driven macrophage inflammaging

Abstract

Hyperglycemia induces chronic low-grade inflammation (inflammaging), which is a newly identified contributor to diabetes-related tissue lesions, including the inflammatory bone loss in periodontitis. It is also a secondary senescent pattern mediated by an increased burden of senescent cells and senescence-associated secretory phenotype (SASP). Macrophage is a key SASP-spreading cell and may contribute to the maintenance of SASP response in the periodontal microenvironment. Using a transgenic diabetic model (BLKS/J-Lepr ^db/lepr ^db mice) we identified striking senescence of the periodontium in young (18-wk)-diabetic mice accompanied by amassed p16⁺-macrophages and enhanced early SASP response. Exposed to high glucose in vitro, bone marrow-derived macrophage (BMDM) revealed a strong GLUT1 mRNA response driving the elevated-glucose uptake. GLUT1 is a representative and facilitative glucose transporter in macrophages with potential roles in hyperglycemia-induced inflammation. In this study, both GLUT1 and the downstream GTPase Rheb expression upregulated in the gingiva of diabetic mice with impaired condition. Furthermore, SASP release and p16/p21 signaling were proven to be triggered by mTOR phosphorylation in BMDM and antagonized by restricting glucose uptake in GLUT1 ^{− /−} BMDM. Taken together, our findings suggest that elevated-GLUT1 sensor responded to high glucose is important for macrophage senescence and SASP response, generated as a result of hyperglycemia, and it is a potential molecular mechanism for the exacerbation of periodontitis in diabetes.

References

[1] Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat. Rev. Cardiol., 2018, 15: 505-522.

[2] Chapple IL, Genco R. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J. Periodontol., 2013, 84: S106-S112.

[3] Graves DT, Ding Z, Yang Y. The impact of diabetes on periodontal diseases. Periodontology, 2020, 82: 214-224.

[4] Prattichizzo F, . Inflammageing and metaflammation: The yin and yang of type 2 diabetes. Ageing Res. Rev., 2018, 41: 1-17.

[5] Prattichizzo F, . “Inflammaging” as a druggable target: a senescence-associated secretory phenotype-centered view of type 2 diabetes. Oxid. Med. Cell Longev., 2016, 2016: 1810327.

[6] Franceschi C, . Inflammaging 2018: an update and a model. Semin. Immunol., 2018, 40: 1-5.

[7] Salminen A, Kaarniranta K, Kauppinen A. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging, 2012, 4: 166-175.

[8] Xu M, . JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc. Natl Acad. Sci. USA, 2015, 112: E6301-E6310.

[9] De Cecco M, . L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature, 2019, 566: 73-78.

[10] Hohensinner PJ, . Reduction of premature aging markers after gastric bypass surgery in morbidly obese patients. Obes. Surg., 2018, 28: 2804-2810.

[11] Hekmatimoghaddam S, Dehghani Firoozabadi A, Zare-Khormizi MR, Pourrajab F. Sirt1 and Parp1 as epigenome safeguards and microRNAs as SASP-associated signals, in cellular senescence and aging. Ageing Res. Rev., 2017, 40: 120-141.

[12] Prattichizzo F, . Short-term sustained hyperglycaemia fosters an archetypal senescence-associated secretory phenotype in endothelial cells and macrophages. Redox Biol., 2018, 15: 170-181.

[13] Yu T, . Enhanced activity of the macrophage M1/M2 phenotypes and phenotypic switch to M1 in periodontal infection. J. Periodontol., 2016, 87: 1092-1102.

[14] Xu M, . Targeting senescent cells enhances adipogenesis and metabolic function in old age. Elife, 2015, 4

[15] Palmer AK, . Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell, 2019, 18

[16] Fu Y, Maianu L, Melbert BR, Garvey WT. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol. Dis., 2004, 32: 182-190.

[17] Freemerman AJ, . Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J. Biol. Chem., 2014, 289: 7884-7896.

[18] Cho SJ, Moon JS, Lee CM, Choi AM, Stout-Delgado HW. Glucose transporter 1-dependent glycolysis is increased during aging-related lung fibrosis, and phloretin inhibits lung fibrosis. Am. J. Respir. Cell Mol. Biol., 2017, 56: 521-531.

[19] Erbel C, . Differential regulation of aldose reductase expression during macrophage polarization depends on hyperglycemia. Innate Immun., 2016, 22: 230-237.

[20] Choi HY, . High glucose causes human cardiac progenitor cell dysfunction by promoting mitochondrial fission: role of a GLUT1 blocker. Biomol. Ther., 2016, 24: 363-370.

[21] You ZP, . Suppression of diabetic retinopathy with GLUT1 siRNA. Sci. Rep., 2017, 7

[22] Zhou X, . Metformin ameliorates experimental diabetic periodontitis independently of mammalian target of rapamycin (mTOR) inhibition by reducing NIMA-related kinase 7(Nek7) expression. J. Periodontol., 2019, 90: 1032-1042.

[23] Buller CL, . GLUT1 enhances mTOR activity independently of TSC2 and AMPK. Am. J. Physiol. Ren. Physiol., 2011, 301: F588-F596.

[24] Saxton RA, . mTOR signaling in growth, metabolism, and disease. Cell, 2017, 168: 960-976.

[25] Sun SC. The non-canonical NF-kappaB pathway in immunity and inflammation. Nat. Rev. Immunol., 2017, 17: 545-558.

[26] Hearps AC, . Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell, 2012, 11: 867-875.

[27] Chen L, . 1,25-Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling. Aging Cell, 2019, 18

[28] Krishnamurthy J, . Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest., 2004, 114: 1299-1307.

[29] Baker DJ, . Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature, 2016, 530: 184-189.

[30] Zhang Z, . Granulocyte colony stimulating factor (G-CSF) regulates neutrophils infiltration and periodontal tissue destruction in an experimental periodontitis. Mol. Immunol., 2020, 117: 110-121.

[31] Ebersole JL, . Aging, inflammation, immunity and periodontal disease. Periodontol 2000, 2016, 72: 54-75.

[32] Jeon OH, . Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med., 2017, 23: 775-781.

[33] Zhuang Y, Lyga J. Inflammaging in skin and other tissues—the roles of complement system and macrophage. Inflamm. Allergy Drug Targets, 2014, 13: 153-161.

[34] Shapira L, Soskolne WA, Sela MN, Offenbacher S, Barak V. The secretion of PGE2, IL-1 beta, IL-6, and TNF alpha by adherent mononuclear cells from early onset periodontitis patients. J. Periodontol., 1994, 65: 139-146.

[35] Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr. Rev., 2008, 29: 351-366.

[36] Xiao E, . Diabetes enhances IL-17 expression and alters the oral microbiome to increase its pathogenicity. Cell Host Microbe, 2017, 22: 120-128 e124.

[37] Wu YY, Xiao E, Graves DT. Diabetes mellitus related bone metabolism and periodontal disease. Int. J. Oral. Sci., 2015, 7: 63-72.

[38] Li H, . Experimental periodontitis induced by Porphyromonas gingivalis does not alter the onset or severity of diabetes in mice. J. Periodontal. Res, 2013, 48: 582-590.

[39] Khosla S, . The role of cellular senescence in ageing and endocrine disease. Nat. Rev. Endocrinol., 2020, 16: 263-275.

[40] Laberge RM, . MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat. Cell Biol., 2015, 17: 1049-1061.

[41] Inoki K, . Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev., 2003, 17: 1829-1834.

[42] Moiseeva O, . Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-kappaB activation. Aging Cell, 2013, 12: 489-498.

[43] Wu J, . Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation. Am. J. Pathol., 2010, 176: 2163-2176.

[44] Hummel KP, Coleman DL, Lane PW. The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL-6J strains. Biochem. Genet., 1972, 7: 1-13.

[45] Fischer LJ, Rickert DE. Pancreatic islet-cell toxicity. CRC Crit. Rev. Toxicol., 1975, 3: 231-263.

[46] Wang B, Chandrasekera PC, Pippin JJ. Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr. Diabet. Rev., 2014, 10: 131-145.

[47] Zhang P, . 25-Hydroxyvitamin D3-enhanced PTPN2 positively regulates periodontal inflammation through the JAK/STAT pathway in human oral keratinocytes and a mouse model of type 2 diabetes mellitus. J. Periodontal. Res., 2018, 53: 467-477.

[48] Park CH, . Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. J. Periodontol., 2007, 78: 273-281.

[49] Sasaki H, . T cell response mediated by myeloid cell-derived IL-12 is responsible for Porphyromonas gingivalis-induced periodontitis in IL-10-deficient mice. J. Immunol., 2008, 180: 6193-6198.

[50] Hu D, . Human kallikrein overexpression alleviates cardiac aging by alternatively regulating macrophage polarization in aged rats. FASEB J., 2019, 33: 8436-8452.

[51] Leenen PJ, Canono BP, Drevets DA, Voerman JS, Campbell PA. TNF-alpha and IFN-gamma stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J. Immunol., 1994, 153: 5141-5147.

[52] Beklen A, Hukkanen M, Richardson R, Konttinen YT. Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Oral. Microbiol. Immunol., 2008, 23: 425-431.

Funding

International Cooperation Project of Chengdu Municipal Science and Technology Bureau [grant number 2015-GH02-00035-HZ]

National Natural Science Foundation of China (National Science Foundation of China)(81991500; 81991502)